Literature DB >> 9526563

Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities.

D E Bierer1, D M Fort, C D Mendez, J Luo, P A Imbach, L G Dubenko, S D Jolad, R E Gerber, J Litvak, Q Lu, P Zhang, M J Reed, N Waldeck, R C Bruening, B K Noamesi, R F Hector, T J Carlson, S R King.   

Abstract

Using an ethnobotanical approach in combination with in vivo-guided fractionation as a means for lead discovery, cryptolepine was isolated as an antihyperglycemic component of Cryptolepis sanguinolenta. Two syntheses of cryptolepine, including an unambiguous synthesis, are reported. The hydroiodide, hydrochloride, and hydrotrifluoromethanesulfonate (hydrotriflate) salts of cryptolepine were synthesized, and a comparison of their spectral properties and their in vitro activities in a 3T3-L1 glucose transport assay is made. Cryptolepine and its salt forms lower blood glucose in rodent models of type II diabetes. While a number of bioactivities have been reported for cryptolepine, this is the first report that cryptolepine possesses antihyperglycemic properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526563     DOI: 10.1021/jm9704816

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  Synergistic anti-malarial action of cryptolepine and artemisinins.

Authors:  Arnold D Forkuo; Charles Ansah; Kwesi M Boadu; Johnson N Boampong; Elvis O Ameyaw; Ben A Gyan; Andrea T Arku; Michael F Ofori
Journal:  Malar J       Date:  2016-02-16       Impact factor: 2.979

2.  Design and in vitro haemolytic evaluation of cryptolepine hydrochloride-loaded gelatine nanoparticles as a novel approach for the treatment of malaria.

Authors:  Noble Kuntworbe; Raida Al-Kassas
Journal:  AAPS PharmSciTech       Date:  2012-04-05       Impact factor: 3.246

3.  Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens.

Authors:  Comfort A Boateng; Suresh V K Eyunni; Xue Y Zhu; Jagan R Etukala; Barbara A Bricker; M K Ashfaq; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2010-11-10       Impact factor: 3.641

4.  Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents.

Authors:  Xue Y Zhu; Leroy G Mardenborough; Shouming Li; Abdul Khan; Wang Zhang; Pincheng Fan; Melissa Jacob; Shabana Khan; Larry Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2006-11-01       Impact factor: 3.641

5.  Clinical efficacy of a tea-bag formulation of cryptolepis sanguinolenta root in the treatment of acute uncomplicated falciparum malaria.

Authors:  K A Bugyei; G L Boye; M E Addy
Journal:  Ghana Med J       Date:  2010-03

6.  Recent Advances in the Chemistry and Pharmacology of Cryptolepine.

Authors:  Steven D Shnyder; Colin W Wright
Journal:  Prog Chem Org Nat Prod       Date:  2021

Review 7.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Authors:  Eyunni V K Suresh Kumar; Jagan R Etukala; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

8.  Recombinagenic effect of cryptolepine in uvsH+//uvsH+ and uvsH//uvsH diploid strains of Aspergillus nidulans.

Authors:  S J R Chiuchetta; M A A Castro-Prado
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

9.  Antifertility activity of Cryptolepis sanguinolenta leaf ethanolic extract in male rats.

Authors:  Ayodeji F Ajayi; Roland E Akhigbe
Journal:  J Hum Reprod Sci       Date:  2012-01

10.  Synthesis and Evaluation of the Tetracyclic Ring-System of Isocryptolepine and Regioiso-Mers for Antimalarial, Antiproliferative and Antimicrobial Activities.

Authors:  Katja S Håheim; Emil Lindbäck; Kah Ni Tan; Marte Albrigtsen; Ida T Urdal Helgeland; Clémence Lauga; Théodora Matringe; Emily K Kennedy; Jeanette H Andersen; Vicky M Avery; Magne O Sydnes
Journal:  Molecules       Date:  2021-05-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.